Document Detail


Frequency of RAS and p53 mutations in acute promyelocytic leukemias.
MedLine Citation:
PMID:  8124213     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The frequency of RAS and p53 mutations was investigated in 30 acute promyelocytic leukemias by single strand conformation polymorphism analysis and direct sequencing of genomic DNA. Only two cases bore N-RAS codon 12 mutations and none had p53 mutations responsible for aminoacid substitutions. It would, therefore, seem that neither RAS nor p53 are involved in acute promyelocytic leukemogenesis.
Authors:
L Longo; D Trecca; A Biondi; F Lo Coco; F Grignani; A T Maiolo; P G Pelicci; A Neri
Related Documents :
12235453 - Increased genotype frequency of n-acetyltransferase 2 slow acetylation in patients with...
7870083 - Absence of ki-ras mutations in exocrine pancreatic tumors from male rats chronically ex...
10323403 - A novel 9-base pair duplication in ret exon 8 in familial medullary thyroid carcinoma.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  11     ISSN:  1042-8194     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  1993 Nov 
Date Detail:
Created Date:  1994-04-11     Completed Date:  1994-04-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  405-10     Citation Subset:  IM    
Affiliation:
Istituto Clinica Medica I, University of Perugia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Base Sequence
Genes, p53*
Genes, ras*
Humans
Leukemia, Promyelocytic, Acute / etiology,  genetics*
Molecular Sequence Data
Mutation*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of refractory and relapsed adult acute leukemia using a uniform chemotherapy protocol.
Next Document:  Intratumoral production of IL-6 in B cell chronic lymphocytic leukemia and B lymphomas.